SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-01-05 13:37
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Elliott, Christine Janice
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,123
+3,605 vol
$4.75 each 		11,275
Filed 2026-01-05 13:35
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Roy, Christian
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,123
+3,605 vol
$4.75 each 		103,461
Filed 2026-01-05 13:34
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Roy, Christian
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$19,693
+4,146 vol
$4.75 each 		99,856
Filed 2026-01-05 13:32
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,123
+3,605 vol
$4.75 each 		127,938
Filed 2026-01-05 13:32
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$23,118
+4,867 vol
$4.75 each 		124,333
Filed 2026-01-05 13:30
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,123
+3,605 vol
$4.75 each 		116,043
Filed 2026-01-05 13:28
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$23,973
+5,047 vol
$4.75 each 		229,130
Filed 2026-01-05 13:28
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$32,532
+6,849 vol
$4.75 each 		224,083
Filed 2026-01-05 13:25
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,123
+3,605 vol
$4.75 each 		132,469
Filed 2026-01-05 13:25
Tx date 2025-12-31 		$HLS
HLS Therapeutics Inc. 		Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$5,567
+1,172 vol
$4.75 each 		128,864
Filed 2025-10-07 16:35
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Elliott, Christine Janice
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,398
+3,246 vol
$5.36 each 		7,670
Filed 2025-10-07 16:33
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Roy, Christian
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$37,402
+6,978 vol
$5.36 each 		95,710
Filed 2025-10-07 16:30
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,398
+3,246 vol
$5.36 each 		112,438
Filed 2025-10-07 16:29
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,398
+3,246 vol
$5.36 each
Filed 2025-10-07 16:27
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$40,886
+7,628 vol
$5.36 each 		119,466
Filed 2025-10-07 16:23
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Hill, Rodney Graham
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$17,398
+3,246 vol
$5.36 each
Filed 2025-10-07 16:20
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$57,410
+10,711 vol
$5.36 each 		217,234
Filed 2025-10-07 16:16
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		Beauchamp, Norma
4 - Director of Issuer
Direct Ownership
DSU
56 - Grant of rights 		$23,053
+4,301 vol
$5.36 each 		127,692
Filed 2025-09-30 16:36
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,500 vol 		0
Filed 2025-09-30 16:36
Tx date 2025-09-30 		$HLS
HLS Therapeutics Inc. 		HLS Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$5,755
+1,000 vol
$5.75 each 		1,500